Novartis to Open, at FDA Request, New Trial of Zolgensma for Older Patients
SMA News Today’s multimedia associate, Price Wooldridge, discusses Novartis opening, at FDA request, a new trial of Zolgensma for older patients. Are you interested in learning more about spinal musc...
9 Loka 20207min
How SMA Affects Your Ability to Draw, Treasuring Little Things & Setting Boundaries With Caregivers
Forums Director Kevin Schaefer talks about how SMA has affected his ability to draw, and about treasuring the little things. Recent topics being discussed in the SMA News Today forums include setting...
7 Loka 20205min
#67 - Interview With Maylan Chavez
In episode 67, host Kevin Schaefer talks with Maylan Chavez from Miami, Florida. Maylan is an ambassador for the company EyeGaze Inc., which develops eye tracking technology for people with disabiliti...
6 Loka 202037min
Spinraza Leads To Motor Gains Over Time in SMA Type 3 Adults
SMA News Today’s multimedia associate, Price Wooldridge, discusses how Spinraza leads to motor gains over time in Spinal Muscular Atrophy (SMA) Type 3 adults, according to a real-life study. DeAnn Ru...
5 Loka 20209min
GridPad Trilogy Communication Device Aids People With Speech And Motor Disorders Who Have SMA
SMA News Today’s multimedia associate, Price Wooldridge, discusses the GridPad Trilogy communication device, which aids people with speech and motor disorders who have Spinal Muscular Atrophy (SMA). ...
2 Loka 20204min
Kevin Schaefer Talks About How The Past Few Months Have Been And How He’s Adapted to a New Normal
Forums Director Kevin Schaefer talks about how the past few months have been for him, and how he’s adapted to a new normal. To learn more about spinal muscular atrophy, visit our website at http://ww...
30 Syys 20203min
Electric Bike Technologies Donates Liberty Trikes To Aid The Mobility Of Children With SMA
SMA News Today’s multimedia associate, Price Wooldridge, discusses the Electric Bike Technologies company donating Liberty Trikes to aid the mobility of children with Spinal Muscular Atrophy (SMA) and...
28 Syys 20205min
AveXis Now Known as Novartis Gene Therapies, Focus of Continuing Work
SMA News Today’s multimedia associate, Price Wooldridge, discusses AveXis, now known as Novartis Gene Therapies, focusing on continued work with genetic diseases. Are you interested in learning more ...
25 Syys 20204min
